Cardiovascular Clinical Highlights – June 2020
Amyloid/Sarcoid Clinical Program Update Amyloidosis is a condition caused by the deposition of misfolded proteins in tissues including the heart, nerves, and kidneys. Cardiac amyloidosis has been considered a rare…
UVA Advanced Cardiac Valve Program
UVA Valve Program Expansion: The Advanced Cardiac Valve Program at UVA, under the leadership of Drs. Scott Lim and Gorav Ailawadi, has had a dynamic year with significant growth and…
Latino Community Health Initiative During COVID-19
Latinos are among the most vulnerable populations during the COVID-19 pandemic for the following reasons: • Language barriers are highly prevalent and limit the effectiveness of communications between the patients,…
Valvular heart diseases related to rheumatic fever is common in sub-Sahara Africa and especially Zambia, a country located in southern Africa. Because of the general lack of local cardiovascular expertise…
Division of Cardiovascular Medicine Chief Message
University of Virginia’s Division of Cardiovascular Medicine, led by Christopher M. Kramer, MD, is nationally recognized for excellence in clinical care, research, and teaching. Faculty members provide expert, comprehensive care…
Asthma, Allergy, and Immunology Clinical Updates – May 2020
Food allergy We are establishing an extensive network for the diagnosis and management of food allergies including protocols for advanced diagnostic testing and challenges. Patients are also invited as appropriate…
